Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia [Phase 1, Phase 2]
The document reports the completion of a randomized Phase 1/2 trial studying intensive computer-based cognitive remediation in individuals w…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Genes, Intermediate Phenotypes and Response to Quetiapine RX
A completed clinical trial investigating how genes and intermediate phenotypes relate to response to quetiapine in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Glutamate, Learning, and Working Memory [Phase 1]
A Phase 1 UCLA clinical trial investigating how glutamate influences learning and working memory in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Single Ascending Dose Study of RBP-7000 [Phase 1]
Phase 1 single ascending dose study of RBP-7000 in schizophrenia completed; results are not detailed in the snippet provided.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 [Phase 1]
First-in-man Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of RBP-7000 in schizophrenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]
Phase 3 trial evaluating EVP-6124 as an adjunct pro-cognitive treatment in schizophrenia patients on stable antipsychotic therapy has comple…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]
Reports results of a 26-week extension study of EVP-6124 (encenicline), an alpha-7 nicotinic receptor agonist, as adjunctive pro-cognitive t…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]
This update covers a Phase 3 trial of EVP-6124 (encenicline), an alpha-7 nicotinic receptor agonist, used as adjunctive pro-cognitive therap…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia [Phase 3]
This Phase 3 clinical trial update reports results for the paliperidone palmitate 3-month and 1-month formulations in schizophrenia. Results…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities [Phase 4]
Phase 4 trial evaluating adjunctive low-dose metformin in patients with schizophrenia and metabolic abnormalities (metabolic syndrome) has c…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Remediation of Working Memory in Schizophrenia [NA]
A completed clinical trial evaluating remediation of working memory in schizophrenia and schizoaffective disorder, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... [NA]
This clinical trial update reports the completed efficacy evaluation of two metacognitive training modules (Jumping to Conclusions and To Em…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Improving Basic and Social Cognition in Veterans With Schizophrenia [NA]
This clinical trial update describes a study aimed at improving basic and social cognition in veterans with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia [Phase 3]
A Phase 3 study evaluating the safety and efficacy of clozapine in treatment-resistant schizophrenia has completed, sponsored by Novartis.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Cognitive Rehabilitation in Schizophrenia [NA]
A completed clinical trial evaluating cognitive rehabilitation in schizophrenia, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia [Phase 4]
A Phase 4 trial evaluating the effects of paliperidone extended-release versus risperidone immediate-release on cognitive function in clinic…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Integrated Coping and Awareness Training [NA]
This clinical trial update reports the completed study of Integrated Coping and Awareness Training for schizophrenia, sponsored by the Unive…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of single doses of APN1125 in healthy normal subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia [Phase 4]
Phase 4 clinical trial evaluating omega-3 fatty acids (Lovaza) for hypertriglyceridemia associated with second-generation antipsychotics. Re…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: DAAOI-1 Treatment for Treatment-resistant Schizophrenia [Phase 2]
A Phase 2 clinical trial of DAAOI-1 for treatment-resistant schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia [Phase 3]
This document reports the completion and posting of results for a Phase 3 monotherapy trial of brexpiprazole in adults with early-episode sc…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Brexpiprazole in Patients With Acute Schizophrenia [Phase 3]
Phase 3 trial evaluating brexpiprazole in patients with acute schizophrenia has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers [Phase 1]
Phase 1 comparative bioavailability study evaluating a 10 mg aripiprazole oral soluble film against the 10 mg Abilify tablet in healthy volu…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia [NA]
This completed clinical trial examined directed forgetting and embodied cognition in people with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of once-weekly zicronapine in adults with schizophrenia has…